Cargando datos de ACHV: primera visita, tardará unos segundos.
Achieve Life Sciences, Inc.
6.51 +0.00 (0.00%)
6.51 +0.00%
- Capitalización de mercado
- $671.2M
- Volumen
- 2.47M
- Próxima fecha de resultados
- Aug 11, 2026
Achieve Life Sciences, Inc. (ACHV): cotización, análisis y datos
Valor intrínseco
Ver planes →Pronóstico del analista
Previsiones bursátiles →$9.00 – $21.00
mediana $13.00 · 99.69% Potencial alcista
Estás viendo el resumen gratuito
Crea una cuenta gratuita para explorar más análisis sobre este valor.
Últimos resultados
| Reportado | Vs. estimación | Cambio interanual | |
|---|---|---|---|
| Ingresos | $0 | n/a | n/a |
| EPS | -$0.19 | +$0.11 | +48.65% |
Métricas
- Precio de compra
- 4.77
- Ingresos (TTM)
- n/a
- Beneficio neto (TTM)
- -114M
- 2.31
- -1.69
- n/a
- -9.98
- P/B (TTM)
- -45.52
- P/S (TTM)
- n/a
- Fecha de resultados
- Aug 11, 2026
- Precio de venta
- 8.19
- Volumen
- 2,467,797
- Volumen medio (20D)
- 1,424,429
- Abierto
- 6.50
- Anterior Cerrar
- 6.51
- Rango del día
- 6.38 - 6.67
- Rango de 52 semanas
- 2.62 - 8.64
- analista
- n/a
- Precio objetivo
- 13 (99.69%)
- Dividendos
- n/a
- Fecha ex dividendo
- n/a
Acerca de Achieve Life Sciences, Inc.
Ver perfil →Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
Industria Biotechnology
Sector Healthcare
IPO Fecha Oct 12, 1995
Empleados 28
Bolsa de Valores NasdaqCM
Símbolo bursátil ACHV
Sitio web https://www.achievelifesciences.com